151 related articles for article (PubMed ID: 32787718)
1. New therapeutic system based on hydrogels for vaginal candidiasis management: formulation-characterization and
Arpa MD; Yoltaş A; Onay Tarlan E; Şenyüz CŞ; Sipahi H; Aydın A; Üstündağ Okur N
Pharm Dev Technol; 2020 Dec; 25(10):1238-1248. PubMed ID: 32787718
[TBL] [Abstract][Full Text] [Related]
2. Development of topical hydrogels of terbinafine hydrochloride and evaluation of their antifungal activity.
Çelebi N; Ermiş S; Özkan S
Drug Dev Ind Pharm; 2015 Apr; 41(4):631-9. PubMed ID: 24576265
[TBL] [Abstract][Full Text] [Related]
3. Advanced topical drug delivery system for the management of vaginal candidiasis.
Johal HS; Garg T; Rath G; Goyal AK
Drug Deliv; 2016; 23(2):550-63. PubMed ID: 24959937
[TBL] [Abstract][Full Text] [Related]
4. Enhanced topical delivery of terbinafine hydrochloride with chitosan hydrogels.
Ozcan I; Abaci O; Uztan AH; Aksu B; Boyacioğlu H; Güneri T; Ozer O
AAPS PharmSciTech; 2009; 10(3):1024-31. PubMed ID: 19662536
[TBL] [Abstract][Full Text] [Related]
5. Bioadhesive vaginal tablets containing spray dried microspheres loaded with clotrimazole for treatment of vaginal candidiasis.
Gupta NV; Natasha S; Getyala A; Bhat RS
Acta Pharm; 2013 Sep; 63(3):359-72. PubMed ID: 24152896
[TBL] [Abstract][Full Text] [Related]
6. Development and in vivo evaluation of chitosan-gel containing Mitracarpus frigidus methanolic extract for vulvovaginal candidiasis treatment.
Campos LM; de Oliveira Lemos AS; da Cruz LF; de Freitas Araújo MG; de Mello Botti GCR; Júnior JLR; Rocha VN; Denadai ÂML; da Silva TP; Tavares GD; Scio E; Fabri RL; Pinto PF
Biomed Pharmacother; 2020 Oct; 130():110609. PubMed ID: 34321177
[TBL] [Abstract][Full Text] [Related]
7. Bioadhesive vaginal drug delivery of nystatin using a derivatized polymer: Development and characterization.
Bassi P; Kaur G
Eur J Pharm Biopharm; 2015 Oct; 96():173-84. PubMed ID: 26235393
[TBL] [Abstract][Full Text] [Related]
8. Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.
Karimunnisa S; Atmaram P
Drug Dev Ind Pharm; 2013 Sep; 39(9):1328-37. PubMed ID: 22866766
[TBL] [Abstract][Full Text] [Related]
9. Formulation and evaluation of butenafine loaded PLGA-nanoparticulate laden chitosan nano gel.
Alshehri S; Imam SS
Drug Deliv; 2021 Dec; 28(1):2348-2360. PubMed ID: 34747275
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of ketoconazole gel-flakes in treatment of vaginal candidiasis: Formulation, in vitro and clinical evaluation.
Abd Ellah NH; Abdel-Aleem JA; Abdo MN; Abou-Ghadir OF; Zahran KM; Hetta HF
Int J Pharm; 2019 Aug; 567():118472. PubMed ID: 31252146
[TBL] [Abstract][Full Text] [Related]
11. Temperature-dependent in Situ Gel of Clotrimazole: an Experimental Study.
Patel VP; Damasiya HM; Kapupara P; Ashara KC
Folia Med (Plovdiv); 2019 Jun; 61(2):266-276. PubMed ID: 31301667
[TBL] [Abstract][Full Text] [Related]
12. Olive oil and clove oil-based nanoemulsion for topical delivery of terbinafine hydrochloride:
Gul U; Khan MI; Madni A; Sohail MF; Rehman M; Rasul A; Peltonen L
Drug Deliv; 2022 Dec; 29(1):600-612. PubMed ID: 35174738
[TBL] [Abstract][Full Text] [Related]
13. Tailoring thixotropic mixed-lipid nanoconstructs of voriconazole for the management of Vulvovaginal candidiasis: Formulation, statistical optimization,
Abd-Elsalam WH; Nagy YI; Abouelatta SM
Drug Deliv; 2021 Dec; 28(1):1877-1889. PubMed ID: 34519230
[TBL] [Abstract][Full Text] [Related]
14. Surface-modified mucoadhesive microgels as a controlled release system for miconazole nitrate to improve localized treatment of vulvovaginal candidiasis.
Kenechukwu FC; Attama AA; Ibezim EC; Nnamani PO; Umeyor CE; Uronnachi EM; Gugu TH; Momoh MA; Ofokansi KC; Akpa PA
Eur J Pharm Sci; 2018 Jan; 111():358-375. PubMed ID: 28986195
[TBL] [Abstract][Full Text] [Related]
15. Improved vaginal retention and enhanced antifungal activity of miconazole microsponges gel: Formulation development and in vivo therapeutic efficacy in rats.
Salah S; Awad GEA; Makhlouf AIA
Eur J Pharm Sci; 2018 Mar; 114():255-266. PubMed ID: 29288706
[TBL] [Abstract][Full Text] [Related]
16. Formulation, stability study and preclinical evaluation of a vaginal cream containing curcumin in a rat model of vulvovaginal candidiasis.
Fernandes LS; Amorim YM; da Silva EL; Silva SC; Santos AJA; Peixoto FN; Neves Pires LM; Sakamoto RY; Horta Pinto FDC; Scarpa MVC; Araújo MGF
Mycoses; 2018 Oct; 61(10):723-730. PubMed ID: 29517833
[TBL] [Abstract][Full Text] [Related]
17. Microemulsion based vaginal gel of fluconazole: formulation, in vitro and in vivo evaluation.
Bachhav YG; Patravale VB
Int J Pharm; 2009 Jan; 365(1-2):175-9. PubMed ID: 18790032
[TBL] [Abstract][Full Text] [Related]
18. Topical drugs for vaginal candidiasis.
Med Lett Drugs Ther; 1991 Aug; 33(851):81. PubMed ID: 1865851
[No Abstract] [Full Text] [Related]
19. Nanolipid Gel of an Antimycotic Drug for Treating Vulvovaginal Candidiasis-Development and Evaluation.
Takalkar D; Desai N
AAPS PharmSciTech; 2018 Apr; 19(3):1297-1307. PubMed ID: 29340981
[TBL] [Abstract][Full Text] [Related]
20. Mucoadhesive in situ gel formulation for vaginal delivery of clotrimazole: formulation, preparation, and in vitro/in vivo evaluation.
Rençber S; Karavana SY; Şenyiğit ZA; Eraç B; Limoncu MH; Baloğlu E
Pharm Dev Technol; 2017 Jun; 22(4):551-561. PubMed ID: 27055376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
